Adhera Therapeutics Inc
OTC: ATRX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- David A. Battat
- Employees
- 2
- Headquarters
- Baton Rouge, United States
- IPO year
- 1993
- Market cap
- $722.0
- Website
- https://adherathera.com
Loading ATRX…
Loading profile data…Frequently asked questions about ATRX
What does Adhera Therapeutics Inc (ATRX) do?
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson’s disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics...
Where does ATRX trade?
Adhera Therapeutics Inc (ATRX) trades on the Other OTC.
What sector is ATRX in?
Adhera Therapeutics Inc (ATRX) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Adhera Therapeutics Inc?
David A. Battat is the chief executive officer of Adhera Therapeutics Inc (ATRX).
Where is Adhera Therapeutics Inc headquartered?
Adhera Therapeutics Inc is headquartered in United States.
Does ATRX pay a dividend?
Adhera Therapeutics Inc (ATRX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ATRX go public?
Adhera Therapeutics Inc (ATRX) completed its initial public offering in 1993.